nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethotoin—SCN3A—spinal nerve—peripheral nervous system neoplasm	0.0594	0.269	CbGeAlD
Ethotoin—Distress—Tretinoin—peripheral nervous system neoplasm	0.0288	0.0534	CcSEcCtD
Ethotoin—Distress—Isotretinoin—peripheral nervous system neoplasm	0.0288	0.0534	CcSEcCtD
Ethotoin—SCN11A—nerve—peripheral nervous system neoplasm	0.0248	0.112	CbGeAlD
Ethotoin—SCN11A—ganglion—peripheral nervous system neoplasm	0.0244	0.111	CbGeAlD
Ethotoin—Non-Hodgkin's lymphoma—Melphalan—peripheral nervous system neoplasm	0.0226	0.0419	CcSEcCtD
Ethotoin—Lymphoma—Melphalan—peripheral nervous system neoplasm	0.0226	0.0419	CcSEcCtD
Ethotoin—Distress—Alitretinoin—peripheral nervous system neoplasm	0.0218	0.0405	CcSEcCtD
Ethotoin—Emotional distress—Isotretinoin—peripheral nervous system neoplasm	0.0188	0.0349	CcSEcCtD
Ethotoin—Emotional distress—Tretinoin—peripheral nervous system neoplasm	0.0188	0.0349	CcSEcCtD
Ethotoin—SCN8A—nerve—peripheral nervous system neoplasm	0.0188	0.0851	CbGeAlD
Ethotoin—Emotional distress—Alitretinoin—peripheral nervous system neoplasm	0.0143	0.0264	CcSEcCtD
Ethotoin—SCN5A—Cardiac Progenitor Differentiation—LIN28B—peripheral nervous system neoplasm	0.0131	0.0544	CbGpPWpGaD
Ethotoin—SCN10A—nerve—peripheral nervous system neoplasm	0.0126	0.0569	CbGeAlD
Ethotoin—SCN10A—ganglion—peripheral nervous system neoplasm	0.0124	0.0562	CbGeAlD
Ethotoin—SCN11A—trigeminal ganglion—peripheral nervous system neoplasm	0.012	0.0545	CbGeAlD
Ethotoin—SCN7A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.0104	0.0433	CbGpPWpGaD
Ethotoin—SCN7A—trigeminal ganglion—peripheral nervous system neoplasm	0.0102	0.0463	CbGeAlD
Ethotoin—Numbness—Tretinoin—peripheral nervous system neoplasm	0.00964	0.0179	CcSEcCtD
Ethotoin—Numbness—Isotretinoin—peripheral nervous system neoplasm	0.00964	0.0179	CcSEcCtD
Ethotoin—SCN11A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00928	0.0386	CbGpPWpGaD
Ethotoin—Sensory loss—Tretinoin—peripheral nervous system neoplasm	0.00923	0.0171	CcSEcCtD
Ethotoin—Sensory loss—Isotretinoin—peripheral nervous system neoplasm	0.00923	0.0171	CcSEcCtD
Ethotoin—SCN8A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00849	0.0353	CbGpPWpGaD
Ethotoin—Nystagmus—Vincristine—peripheral nervous system neoplasm	0.00817	0.0152	CcSEcCtD
Ethotoin—SCN8A—brainstem—peripheral nervous system neoplasm	0.00805	0.0365	CbGeAlD
Ethotoin—SCN9A—trigeminal ganglion—peripheral nervous system neoplasm	0.008	0.0363	CbGeAlD
Ethotoin—Numbness—Alitretinoin—peripheral nervous system neoplasm	0.00731	0.0136	CcSEcCtD
Ethotoin—Numbness—Vincristine—peripheral nervous system neoplasm	0.00704	0.0131	CcSEcCtD
Ethotoin—Sensory loss—Alitretinoin—peripheral nervous system neoplasm	0.00699	0.013	CcSEcCtD
Ethotoin—SCN9A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00687	0.0285	CbGpPWpGaD
Ethotoin—Lymphadenopathy—Tretinoin—peripheral nervous system neoplasm	0.0068	0.0126	CcSEcCtD
Ethotoin—Lymphadenopathy—Isotretinoin—peripheral nervous system neoplasm	0.0068	0.0126	CcSEcCtD
Ethotoin—Sensory loss—Vincristine—peripheral nervous system neoplasm	0.00674	0.0125	CcSEcCtD
Ethotoin—SCN3A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00657	0.0273	CbGpPWpGaD
Ethotoin—SCN4A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00631	0.0262	CbGpPWpGaD
Ethotoin—SCN2A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00631	0.0262	CbGpPWpGaD
Ethotoin—SCN10A—trigeminal ganglion—peripheral nervous system neoplasm	0.00609	0.0276	CbGeAlD
Ethotoin—SCN1A—brainstem—peripheral nervous system neoplasm	0.00609	0.0276	CbGeAlD
Ethotoin—SCN1A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00608	0.0253	CbGpPWpGaD
Ethotoin—SCN10A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00608	0.0253	CbGpPWpGaD
Ethotoin—Numbness—Etoposide—peripheral nervous system neoplasm	0.00571	0.0106	CcSEcCtD
Ethotoin—SCN2A—brainstem—peripheral nervous system neoplasm	0.00559	0.0253	CbGeAlD
Ethotoin—Sensory loss—Etoposide—peripheral nervous system neoplasm	0.00546	0.0101	CcSEcCtD
Ethotoin—Lymphadenopathy—Alitretinoin—peripheral nervous system neoplasm	0.00515	0.00957	CcSEcCtD
Ethotoin—SCN7A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00509	0.0211	CbGpPWpGaD
Ethotoin—SCN11A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00453	0.0188	CbGpPWpGaD
Ethotoin—Stevens-Johnson syndrome—Isotretinoin—peripheral nervous system neoplasm	0.00443	0.00823	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Tretinoin—peripheral nervous system neoplasm	0.00443	0.00823	CcSEcCtD
Ethotoin—SCN5A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.00428	0.0178	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00419	0.0174	CbGpPWpGaD
Ethotoin—SCN8A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00415	0.0172	CbGpPWpGaD
Ethotoin—Hypoaesthesia—Topotecan—peripheral nervous system neoplasm	0.00403	0.00747	CcSEcCtD
Ethotoin—Hypoaesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00399	0.00741	CcSEcCtD
Ethotoin—Hypoaesthesia—Tretinoin—peripheral nervous system neoplasm	0.00399	0.00741	CcSEcCtD
Ethotoin—Ataxia—Vincristine—peripheral nervous system neoplasm	0.00399	0.0074	CcSEcCtD
Ethotoin—SCN8A—cerebellum—peripheral nervous system neoplasm	0.00397	0.018	CbGeAlD
Ethotoin—SCN7A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00394	0.0164	CbGpPWpGaD
Ethotoin—Erythema multiforme—Tretinoin—peripheral nervous system neoplasm	0.0038	0.00704	CcSEcCtD
Ethotoin—Erythema multiforme—Isotretinoin—peripheral nervous system neoplasm	0.0038	0.00704	CcSEcCtD
Ethotoin—Nystagmus—Epirubicin—peripheral nervous system neoplasm	0.00371	0.00689	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Dactinomycin—peripheral nervous system neoplasm	0.00362	0.00673	CcSEcCtD
Ethotoin—SCN11A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00351	0.0146	CbGpPWpGaD
Ethotoin—Nystagmus—Doxorubicin—peripheral nervous system neoplasm	0.00343	0.00637	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Alitretinoin—peripheral nervous system neoplasm	0.00336	0.00624	CcSEcCtD
Ethotoin—SCN5A—Cardiac Progenitor Differentiation—NCAM1—peripheral nervous system neoplasm	0.00336	0.014	CbGpPWpGaD
Ethotoin—SCN9A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00335	0.0139	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00321	0.0133	CbGpPWpGaD
Ethotoin—SCN3A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00321	0.0133	CbGpPWpGaD
Ethotoin—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.0031	0.00576	CcSEcCtD
Ethotoin—SCN2A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00308	0.0128	CbGpPWpGaD
Ethotoin—SCN4A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00308	0.0128	CbGpPWpGaD
Ethotoin—Hypoaesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00303	0.00562	CcSEcCtD
Ethotoin—SCN1A—cerebellum—peripheral nervous system neoplasm	0.003	0.0136	CbGeAlD
Ethotoin—Chest pain—Topotecan—peripheral nervous system neoplasm	0.003	0.00557	CcSEcCtD
Ethotoin—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.00298	0.00552	CcSEcCtD
Ethotoin—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.00298	0.00552	CcSEcCtD
Ethotoin—SCN10A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00297	0.0123	CbGpPWpGaD
Ethotoin—SCN1A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00297	0.0123	CbGpPWpGaD
Ethotoin—Chest pain—Melphalan—peripheral nervous system neoplasm	0.00294	0.00545	CcSEcCtD
Ethotoin—Hypoaesthesia—Vincristine—peripheral nervous system neoplasm	0.00292	0.00541	CcSEcCtD
Ethotoin—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.00288	0.00534	CcSEcCtD
Ethotoin—SCN7A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00281	0.0117	CbGpPWpGaD
Ethotoin—SCN2A—cerebellum—peripheral nervous system neoplasm	0.00275	0.0125	CbGeAlD
Ethotoin—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.00262	0.00487	CcSEcCtD
Ethotoin—SCN9A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00259	0.0108	CbGpPWpGaD
Ethotoin—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.00258	0.00479	CcSEcCtD
Ethotoin—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.00258	0.00479	CcSEcCtD
Ethotoin—SCN11A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.0025	0.0104	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00248	0.0103	CbGpPWpGaD
Ethotoin—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00248	0.0046	CcSEcCtD
Ethotoin—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00246	0.00456	CcSEcCtD
Ethotoin—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00246	0.00456	CcSEcCtD
Ethotoin—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00243	0.0045	CcSEcCtD
Ethotoin—SCN3A—cerebellum—peripheral nervous system neoplasm	0.00242	0.011	CbGeAlD
Ethotoin—SCN2A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00238	0.00991	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00238	0.00991	CbGpPWpGaD
Ethotoin—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.00236	0.00439	CcSEcCtD
Ethotoin—SCN1A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.0023	0.00956	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.0023	0.00956	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00229	0.00952	CbGpPWpGaD
Ethotoin—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00227	0.00422	CcSEcCtD
Ethotoin—Lymphadenopathy—Epirubicin—peripheral nervous system neoplasm	0.00226	0.00419	CcSEcCtD
Ethotoin—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00225	0.00418	CcSEcCtD
Ethotoin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00225	0.00418	CcSEcCtD
Ethotoin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00225	0.00418	CcSEcCtD
Ethotoin—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00225	0.00417	CcSEcCtD
Ethotoin—SCN5A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00209	0.00868	CbGpPWpGaD
Ethotoin—Lymphadenopathy—Doxorubicin—peripheral nervous system neoplasm	0.00209	0.00387	CcSEcCtD
Ethotoin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00206	0.00383	CcSEcCtD
Ethotoin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00205	0.0038	CcSEcCtD
Ethotoin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00205	0.0038	CcSEcCtD
Ethotoin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00202	0.00375	CcSEcCtD
Ethotoin—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00201	0.00373	CcSEcCtD
Ethotoin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00197	0.00365	CcSEcCtD
Ethotoin—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00196	0.00363	CcSEcCtD
Ethotoin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00195	0.00362	CcSEcCtD
Ethotoin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00195	0.00362	CcSEcCtD
Ethotoin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00193	0.00357	CcSEcCtD
Ethotoin—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.00192	0.00357	CcSEcCtD
Ethotoin—SCN7A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00192	0.00799	CbGpPWpGaD
Ethotoin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.0019	0.00353	CcSEcCtD
Ethotoin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00189	0.0035	CcSEcCtD
Ethotoin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00189	0.0035	CcSEcCtD
Ethotoin—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00188	0.0035	CcSEcCtD
Ethotoin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00186	0.00346	CcSEcCtD
Ethotoin—SCN9A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00185	0.0077	CbGpPWpGaD
Ethotoin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00184	0.00342	CcSEcCtD
Ethotoin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00183	0.00339	CcSEcCtD
Ethotoin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00181	0.00337	CcSEcCtD
Ethotoin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00181	0.00337	CcSEcCtD
Ethotoin—Rash—Topotecan—peripheral nervous system neoplasm	0.00181	0.00336	CcSEcCtD
Ethotoin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00181	0.00336	CcSEcCtD
Ethotoin—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.00181	0.00336	CcSEcCtD
Ethotoin—Headache—Topotecan—peripheral nervous system neoplasm	0.0018	0.00334	CcSEcCtD
Ethotoin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.0018	0.00334	CcSEcCtD
Ethotoin—Rash—Tretinoin—peripheral nervous system neoplasm	0.0018	0.00334	CcSEcCtD
Ethotoin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.0018	0.00333	CcSEcCtD
Ethotoin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.0018	0.00333	CcSEcCtD
Ethotoin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.0018	0.00333	CcSEcCtD
Ethotoin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00179	0.00332	CcSEcCtD
Ethotoin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00179	0.00332	CcSEcCtD
Ethotoin—Headache—Tretinoin—peripheral nervous system neoplasm	0.00179	0.00332	CcSEcCtD
Ethotoin—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.00178	0.0033	CcSEcCtD
Ethotoin—Rash—Melphalan—peripheral nervous system neoplasm	0.00178	0.00329	CcSEcCtD
Ethotoin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00177	0.00329	CcSEcCtD
Ethotoin—SCN3A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00177	0.00736	CbGpPWpGaD
Ethotoin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00176	0.00327	CcSEcCtD
Ethotoin—SCN11A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00171	0.00712	CbGpPWpGaD
Ethotoin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00171	0.00317	CcSEcCtD
Ethotoin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00171	0.00317	CcSEcCtD
Ethotoin—SCN4A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.0017	0.00707	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.0017	0.00707	CbGpPWpGaD
Ethotoin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00169	0.00314	CcSEcCtD
Ethotoin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00169	0.00314	CcSEcCtD
Ethotoin—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.00167	0.00311	CcSEcCtD
Ethotoin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00167	0.0031	CcSEcCtD
Ethotoin—Nausea—Melphalan—peripheral nervous system neoplasm	0.00167	0.0031	CcSEcCtD
Ethotoin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00165	0.00306	CcSEcCtD
Ethotoin—SCN1A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00164	0.00682	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00164	0.00682	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.00162	0.00672	CbGpPWpGaD
Ethotoin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.0016	0.00296	CcSEcCtD
Ethotoin—SCN8A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00157	0.00651	CbGpPWpGaD
Ethotoin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00155	0.00288	CcSEcCtD
Ethotoin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00149	0.00277	CcSEcCtD
Ethotoin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00148	0.00275	CcSEcCtD
Ethotoin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00148	0.00274	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00147	0.00273	CcSEcCtD
Ethotoin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00147	0.00273	CcSEcCtD
Ethotoin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00146	0.0027	CcSEcCtD
Ethotoin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00145	0.0027	CcSEcCtD
Ethotoin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00265	CcSEcCtD
Ethotoin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00143	0.00264	CcSEcCtD
Ethotoin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00138	0.00257	CcSEcCtD
Ethotoin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00138	0.00256	CcSEcCtD
Ethotoin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.00255	CcSEcCtD
Ethotoin—SCN7A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00137	0.0057	CbGpPWpGaD
Ethotoin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00253	CcSEcCtD
Ethotoin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00253	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00136	0.00252	CcSEcCtD
Ethotoin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00135	0.00251	CcSEcCtD
Ethotoin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00133	0.00248	CcSEcCtD
Ethotoin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00132	0.00246	CcSEcCtD
Ethotoin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00132	0.00246	CcSEcCtD
Ethotoin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00132	0.00245	CcSEcCtD
Ethotoin—Rash—Vincristine—peripheral nervous system neoplasm	0.00131	0.00244	CcSEcCtD
Ethotoin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00131	0.00243	CcSEcCtD
Ethotoin—Headache—Vincristine—peripheral nervous system neoplasm	0.0013	0.00242	CcSEcCtD
Ethotoin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.00238	CcSEcCtD
Ethotoin—SCN9A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00127	0.00527	CbGpPWpGaD
Ethotoin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00126	0.00234	CcSEcCtD
Ethotoin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00234	CcSEcCtD
Ethotoin—Nausea—Vincristine—peripheral nervous system neoplasm	0.00124	0.0023	CcSEcCtD
Ethotoin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.00227	CcSEcCtD
Ethotoin—SCN11A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00122	0.00508	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00121	0.00504	CbGpPWpGaD
Ethotoin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00121	0.00225	CcSEcCtD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.0012	0.00501	CbGpPWpGaD
Ethotoin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00117	0.00217	CcSEcCtD
Ethotoin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00216	CcSEcCtD
Ethotoin—SCN2A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00116	0.00484	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00116	0.00484	CbGpPWpGaD
Ethotoin—Rash—Cisplatin—peripheral nervous system neoplasm	0.00116	0.00216	CcSEcCtD
Ethotoin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00116	0.00215	CcSEcCtD
Ethotoin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00115	0.00214	CcSEcCtD
Ethotoin—SCN5A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.00115	0.00479	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00112	0.00467	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00112	0.00467	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00112	0.00465	CbGpPWpGaD
Ethotoin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00112	0.00207	CcSEcCtD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.0011	0.00459	CbGpPWpGaD
Ethotoin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00203	CcSEcCtD
Ethotoin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00107	0.00199	CcSEcCtD
Ethotoin—Rash—Etoposide—peripheral nervous system neoplasm	0.00106	0.00197	CcSEcCtD
Ethotoin—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.00106	0.00442	CbGpPWpGaD
Ethotoin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00106	0.00197	CcSEcCtD
Ethotoin—Headache—Etoposide—peripheral nervous system neoplasm	0.00106	0.00196	CcSEcCtD
Ethotoin—Nausea—Etoposide—peripheral nervous system neoplasm	0.001	0.00186	CcSEcCtD
Ethotoin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000987	0.00183	CcSEcCtD
Ethotoin—SCN7A—Axon guidance—MET—peripheral nervous system neoplasm	0.000919	0.00382	CbGpPWpGaD
Ethotoin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000913	0.00169	CcSEcCtD
Ethotoin—SCN9A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000904	0.00376	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000899	0.00374	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000865	0.00359	CbGpPWpGaD
Ethotoin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000855	0.00159	CcSEcCtD
Ethotoin—SCN7A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.00085	0.00353	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000831	0.00345	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000831	0.00345	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—MET—peripheral nervous system neoplasm	0.000819	0.0034	CbGpPWpGaD
Ethotoin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000815	0.00151	CcSEcCtD
Ethotoin—SCN1A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000801	0.00333	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000801	0.00333	CbGpPWpGaD
Ethotoin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000792	0.00147	CcSEcCtD
Ethotoin—SCN5A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000789	0.00328	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000757	0.00315	CbGpPWpGaD
Ethotoin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000755	0.0014	CcSEcCtD
Ethotoin—SCN8A—Axon guidance—MET—peripheral nervous system neoplasm	0.000749	0.00311	CbGpPWpGaD
Ethotoin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000748	0.00139	CcSEcCtD
Ethotoin—SCN8A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000693	0.00288	CbGpPWpGaD
Ethotoin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000692	0.00128	CcSEcCtD
Ethotoin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000679	0.00126	CcSEcCtD
Ethotoin—SCN7A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000671	0.00279	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000656	0.00272	CbGpPWpGaD
Ethotoin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000647	0.0012	CcSEcCtD
Ethotoin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000628	0.00117	CcSEcCtD
Ethotoin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000625	0.00116	CcSEcCtD
Ethotoin—SCN7A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000606	0.00252	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—MET—peripheral nervous system neoplasm	0.000606	0.00252	CbGpPWpGaD
Ethotoin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000601	0.00112	CcSEcCtD
Ethotoin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000599	0.00111	CcSEcCtD
Ethotoin—SCN11A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000598	0.00249	CbGpPWpGaD
Ethotoin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000596	0.00111	CcSEcCtD
Ethotoin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000596	0.00111	CcSEcCtD
Ethotoin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000593	0.0011	CcSEcCtD
Ethotoin—SCN11A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000584	0.00243	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—MET—peripheral nervous system neoplasm	0.000579	0.00241	CbGpPWpGaD
Ethotoin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000579	0.00107	CcSEcCtD
Ethotoin—SCN5A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000563	0.00234	CbGpPWpGaD
Ethotoin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000562	0.00104	CcSEcCtD
Ethotoin—SCN9A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.00056	0.00233	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—MET—peripheral nervous system neoplasm	0.000557	0.00231	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—MET—peripheral nervous system neoplasm	0.000557	0.00231	CbGpPWpGaD
Ethotoin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000556	0.00103	CcSEcCtD
Ethotoin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000552	0.00102	CcSEcCtD
Ethotoin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000551	0.00102	CcSEcCtD
Ethotoin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000548	0.00102	CcSEcCtD
Ethotoin—SCN8A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000547	0.00227	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.00054	0.00225	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—MET—peripheral nervous system neoplasm	0.000537	0.00223	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—MET—peripheral nervous system neoplasm	0.000537	0.00223	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000536	0.00223	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000534	0.00222	CbGpPWpGaD
Ethotoin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.000965	CcSEcCtD
Ethotoin—SCN4A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000515	0.00214	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000515	0.00214	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000511	0.00212	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000496	0.00206	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000496	0.00206	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000494	0.00205	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000479	0.00199	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000455	0.00189	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000449	0.00187	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000443	0.00184	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000432	0.0018	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000427	0.00177	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000423	0.00176	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000416	0.00173	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000413	0.00172	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000407	0.00169	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000407	0.00169	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.0004	0.00166	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000397	0.00165	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000397	0.00165	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000392	0.00163	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000392	0.00163	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000391	0.00162	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000383	0.00159	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000383	0.00159	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000382	0.00159	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000381	0.00159	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	0.000377	0.00157	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000374	0.00155	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000367	0.00153	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000367	0.00153	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000365	0.00151	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000354	0.00147	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000354	0.00147	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000349	0.00145	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000337	0.0014	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000333	0.00138	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000325	0.00135	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000322	0.00134	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000316	0.00131	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000309	0.00129	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000309	0.00129	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000305	0.00127	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000302	0.00126	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000298	0.00124	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000298	0.00124	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000297	0.00123	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.00029	0.00121	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.00029	0.00121	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.00028	0.00116	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.00028	0.00116	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000276	0.00115	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	0.000269	0.00112	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000267	0.00111	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000251	0.00105	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000249	0.00103	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000246	0.00102	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.00024	0.000999	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000238	0.000988	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000236	0.000979	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000235	0.000979	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.00023	0.000955	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000226	0.000941	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000226	0.000941	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000221	0.000918	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000221	0.000918	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000218	0.000907	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000218	0.000907	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000217	0.000903	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000213	0.000885	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000213	0.000885	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.00021	0.000872	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	0.00021	0.000872	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000197	0.000818	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000192	0.000798	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000176	0.000731	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00017	0.000706	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000168	0.000699	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000162	0.000671	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000162	0.000671	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000156	0.000647	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000156	0.000647	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000155	0.000645	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000153	0.000638	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.00015	0.000622	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000148	0.000617	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000143	0.000593	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000143	0.000593	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000141	0.000587	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000138	0.000572	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000138	0.000572	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	0.000123	0.00051	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	0.000118	0.000489	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	0.000113	0.000471	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.00011	0.000455	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	9.67e-05	0.000402	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	7.44e-05	0.000309	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	6.29e-05	0.000261	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	6e-05	0.000249	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	5.91e-05	0.000246	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	4.83e-05	0.000201	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	4.73e-05	0.000197	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.3e-05	5.41e-05	CbGpPWpGaD
